ContractopenCA
COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
National Institutes of HealthDescription
COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS. Recipient: THE LELAND STANFORD JUNIOR UNIVERSITY Award Amount: $25.64M
Requirements
Source: USASpending.gov
Interested in this contract?
Sign up to get match scores, track opportunities, and manage proposals with AI-powered tools.
Contract Details
Value Range
Up to $25,640,000
Deadline
May 31, 2030
Geographic Scope
CA
Status
open
External Links
View Original ListingSee how well this contract matches your organization.
Get Your Match Score